BREAKING

Kilroy Realty Reports Q1 2026 Loss: -$0.16/Share vs $0.35 Expected 27 minutes ago Ecolab Q1 2026: Revenue Hits $4.07B, Up 10% Year-Over-Year 49 minutes ago Nucor Jumps 5.5% After UBS Downgrades to Neutral 2 hours ago LGI Homes Edges Past Q1 2026 Estimates, Posts $0.24 EPS, Revenue Down 9% 3 hours ago Molina Healthcare Jumps 5.7% After Wells Fargo Maintains Equal-Weight 3 hours ago COPT Defense Properties Crushes Q1 2026 Profit Estimates 3 hours ago Cincinnati Financial Delivers 12% Revenue Growth in Q1 2026 3 hours ago Armstrong World Industries Falls Short of Q1 2026 Profit Forecast at $1.69 EPS 3 hours ago Franklin Resources Releases Q2 2026 Financial Results 4 hours ago JetBlue Airways Reports 20.8% Wider Q1 2026 Loss at -$0.87/Share 4 hours ago Kilroy Realty Reports Q1 2026 Loss: -$0.16/Share vs $0.35 Expected 27 minutes ago Ecolab Q1 2026: Revenue Hits $4.07B, Up 10% Year-Over-Year 49 minutes ago Nucor Jumps 5.5% After UBS Downgrades to Neutral 2 hours ago LGI Homes Edges Past Q1 2026 Estimates, Posts $0.24 EPS, Revenue Down 9% 3 hours ago Molina Healthcare Jumps 5.7% After Wells Fargo Maintains Equal-Weight 3 hours ago COPT Defense Properties Crushes Q1 2026 Profit Estimates 3 hours ago Cincinnati Financial Delivers 12% Revenue Growth in Q1 2026 3 hours ago Armstrong World Industries Falls Short of Q1 2026 Profit Forecast at $1.69 EPS 3 hours ago Franklin Resources Releases Q2 2026 Financial Results 4 hours ago JetBlue Airways Reports 20.8% Wider Q1 2026 Loss at -$0.87/Share 4 hours ago

ADVERTISEMENT

KN

KNSA

All KNSA Content

5 articles, transcripts, and reports

Analysis

Kiniksa (KNSA) is trending because ARCALYST growth keeps getting harder to dismiss

Kiniksa Pharmaceuticals (KNSA) moved up after first-quarter 2026 results showed that ARCALYST remains a stronger commercial asset than many small-cap...

April 28, 20265 min read

Breaking News

Kiniksa Pharmaceuticals International (KNSA) Reports Q1 2026 Numbers

Kiniksa Pharmaceuticals International, plc reported first-quarter results that exceeded Wall Street expectations, with the biopharmaceutical company posting diluted earnings of $0.

April 28, 20262 min read

Kiniksa Pharmaceuticals Ltd (KNSA) Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q4 2021 Earnings Conference

February 23, 20221 min read

Kiniksa Pharmaceuticals Ltd (KNSA) 3Q21 Earnings Call

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q3 2021 Earnings Conference

November 8, 20211 min read

ADVERTISEMENT

Kiniksa Pharmaceuticals Ltd (KNSA) Second Quarter 2021 Financial Results

Kiniksa Pharmaceuticals Ltd (NASDAQ: KNSA) Q2 2021 Earnings Conference

August 2, 20211 min read